PYROTECH THERAPEUTICS
Pyrotech is based on ground-breaking discoveries regarding ‘pyroptosis’, which is a type of cell death that controls infections by stimulating strong immune responses.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD956m (Public information from May 2024)
Beijing China (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
* | N/A | Seed | |
* |
| CNY700m | Series A |
* | CNY200m Valuation: CNY4.5b | Series A | |
Total Funding | AUD191m |